Equillium, Inc. Common Stock (EQ) Stock Price

EQStock

$2.18+15.79%52W

Market Cap$138.23M

P/E—

PEG Ratio—

Div yield—

Beta1.93

EQ Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)18.17%

Price vs S&P 500 (4W)-8.22%

VGM Score42.83

Book Value / Share (Quarterly)$0.94

P/TBV (Annual)0.56x

Indicated Dividend (Annual)$0.00

Cash Flow / Share (Quarterly)$-0.30

Price vs S&P 500 (YTD)29.98%

Net Profit Margin (TTM)-19.63%

EPS (TTM)$-0.32

10-Day Avg Trading Volume0.52M

EPS Excl Extra (TTM)$-0.32

EPS (Annual)$-0.39

ROI (Annual)-78.32%

Net Profit Margin (5Y Avg)-1079.66%

Cash / Share (Quarterly)$0.97

ROA (Last FY)-70.24%

Revenue Growth TTM (YoY)-90.43%

EBITD / Share (TTM)$-0.28

ROE (5Y Avg)-86.78%

Operating Margin (TTM)-20.12%

Cash Flow / Share (Annual)$-0.37

P/B Ratio2.14x

P/B Ratio (Quarterly)2.13x

Net Income / Employee (Annual)$-1,722,900

EV / Revenue (TTM)1.61x

Net Interest Coverage (TTM)-97.62x

ROA (TTM)-53.72%

EPS Incl Extra (Annual)$-0.39

Current Ratio (Annual)10.58x

Quick Ratio (Quarterly)18.33x

3-Month Avg Trading Volume0.70M

52-Week Price Return15.79%

Revenue / Employee (TTM)$0

Tangible BV / Share (Quarterly)$0.69

P/S Ratio (Annual)3.10x

Asset Turnover (Annual)1.60x

52-Week High$3.54

Operating Margin (5Y Avg)-1045.45%

EPS Excl Extra (Annual)$-0.39

CapEx CAGR (5Y)-24.98%

26-Week Price Return29.41%

Quick Ratio (Annual)10.43x

13-Week Price Return-0.45%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)18.62x

Enterprise Value$66.08M

Asset Turnover (TTM)1.12x

Book Value / Share Growth (5Y)-30.27%

Revenue / Employee (Annual)$0

Pretax Margin (Annual)-18.75%

Cash / Share (Annual)$0.49

3-Month Return Std Dev85.56%

Net Income / Employee (TTM)$-1,465,800

ROE (Last FY)-78.32%

Net Interest Coverage (Annual)-97.78x

EPS Basic Excl Extra (Annual)$-0.39

P/FCF (TTM)1.55x

Receivables Turnover (TTM)22.01x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-0.32

ROI (TTM)-61.43%

P/S Ratio (TTM)3.10x

Pretax Margin (5Y Avg)-1079.66%

Revenue / Share (Annual)$0.00

Tangible BV / Share (Annual)$0.93

Price vs S&P 500 (52W)-2.52%

Year-to-Date Return41.94%

5-Day Price Return-6.38%

EPS Normalized (Annual)$-0.39

ROA (5Y Avg)-50.70%

Net Profit Margin (Annual)-19.63%

Month-to-Date Return0.00%

Cash Flow / Share (TTM)$-0.23

EBITD / Share (Annual)$-0.41

Operating Margin (Annual)-20.12%

LT Debt / Equity (Annual)0.00x

ROI (5Y Avg)-76.66%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-0.32

P/TBV (Quarterly)0.74x

P/B Ratio (Annual)3.30x

Pretax Margin (TTM)-18.75%

Book Value / Share (Annual)$0.47

Price vs S&P 500 (13W)-3.25%

Beta1.93x

Revenue / Share (TTM)$0.00

ROE (TTM)-61.43%

52-Week Low$0.76

vGradeB

gGradeF

mGradeC

vgmGradeC

EQ Earnings Surprise History

Q2 25-0.16est. -0.18

Q3 25-0.06est. -0.22

Q4 25-0.04est. -0.06

Q1 26-0.06est. -0.04

Q2 26-0.04est. -0.06

EQ Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.31

4.44

4.39

Industry Peers — Pharmaceuticals(571)

Symbol	Value Score	Growth Score	Momentum Score	Price
EQEquillium, Inc. Common Stock	B	F	C	$2.18
LLYEli Lilly & Co.	D	B	B	$1233.66
JNJJohnson & Johnson	D	C	B	$273.14
ABBVABBVIE INC.	D	C	B	$265.79
MRKMerck & Co., Inc.	D	C	A	$156.45
NVSNovartis AG	C	C	C	$159.98
AZNAstraZeneca PLC	C	B	C	$169.66
NVONovo-Nordisk A/S	B	C	C	$48.66
ABTAbbott Laboratories	C	C	B	$116.13
PFEPfizer Inc.	C	D	C	$28.57
VRTXVertex Pharmaceuticals Inc	D	C	B	$552.85
BMYBristol-Myers Squibb Co.	B	B	B	$67.92
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	C	C	$46.02
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	B	C	C	$52.07
REGNRegeneron Pharmaceuticals Inc	C	C	B	$833.56
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	C	$18.35
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	C	$38.10
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	C	$376.37
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	B	$62.07
ALNYAlnylam Pharmaceuticals, Inc.	D	A	D	$240.08
ZTSZOETIS INC.	B	C	D	$77.29
INSMInsmed, Inc.	F	A	C	$123.89
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	$36.47
UTHRUnited Therapeutics Corp	C	C	C	$518.53
GMABGenmab A/S ADS	C	C	B	$34.36
VTRSViatris Inc. Common Stock	B	C	B	$16.72
JAZZJazz Pharmaceuticals, Inc.	B	C	B	$260.23
ASNDAscendis Pharma A/S Ordinary Share	D	A	C	$252.99
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	$80.40
CORTCorcept Therapeutics Inc.	F	C	A	$123.57
BMRNBioMarin Pharmaceuticals Inc	C	C	C	$66.12
ARWRArrowhead Research Corporation	D	A	B	$88.88
ELANElanco Animal Health Incorporated Common Stock	C	B	B	$25.09
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	C	$512.16
CYTKCytokinetics Inc.	F	D	B	$77.46
AXSMAxsome Therapeutics, Inc	D	B	C	$205.48
SMMTSummit Therapeutics Inc. Common Stock	F	—	D	$13.36
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	$63.57
ABVXAbivax SA American Depositary Shares	—	—	C	$117.93
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	D	C	$12.34
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	$368.02
NUVLNuvalent, Inc. Class A Common Stock	—	—	B	$123.96
PTGXProtagonist Therapeutics, Inc	F	B	A	$150.59
SYRESpyre Therapeutics, Inc. Common Stock	—	—	A	$107.36
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	$84.86
TGTXTG Therapeutics, Inc.	D	B	A	$55.42
ALKSAlkermes Inc. plc	D	C	B	$49.21
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	$113.35
ORKAOruka Therapeutics, Inc. Common Stock	F	—	A	$101.82
BLTEBelite Bio, Inc American Depositary Shares	—	—	B	$161.68
COGTCogent Biosciences, Inc. Common Stock	F	—	B	$36.80

About Equillium, Inc. Common Stock

Equillium is a clinical-stage biotechnology company developing novel immunotherapies for severe autoimmune and inflammatory disorders. Its lead candidate, Itolizumab (EQ001), is an anti-CD6 monoclonal antibody designed to modulate pathogenic immune responses while preserving regulatory T cells. The company plans to commercialize its pipeline through partnerships, independent development, or strategic transactions. Additional candidates include EQ101 and EQ302.